Insider Transactions in Q1 2022 at Shattuck Labs, Inc. (STTK)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 28
2022
|
Taylor Schreiber Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,926
+18.71%
|
$15,704
$4.67 P/Share
|
|
Jan 19
2022
|
Tyler Brous |
BUY
Open market or private purchase
|
Direct |
3,000
+1.29%
|
$18,000
$6.87 P/Share
|
|
Jan 18
2022
|
Tyler Brous |
BUY
Open market or private purchase
|
Direct |
2,500
+1.09%
|
$17,500
$7.01 P/Share
|
|
Jan 14
2022
|
Tyler Brous |
BUY
Open market or private purchase
|
Direct |
2,500
+1.1%
|
$17,500
$7.16 P/Share
|
|
Jan 12
2022
|
Erin Ator Thomson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+11.23%
|
$20,000
$2.95 P/Share
|
|
Jan 10
2022
|
Erin Ator Thomson General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,825
+24.83%
|
-
|
|
Jan 10
2022
|
Andrew R Neill Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,325
+23.33%
|
-
|
|
Jan 10
2022
|
Arundathy N. Pandite Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,738
+19.78%
|
-
|
|
Jan 10
2022
|
Casi De Young Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,363
+50.0%
|
-
|